VIR Q3 2020 Earnings — Vir Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

VIRVir Biotechnology, Inc.

$1B

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$188,000-20.7% YoY

Gross Profit

$188,000100.0% margin

Operating Income

-$88M-46603.7% margin

Net Income

-$85M-45004.8% margin

EPS (Diluted)

$-0.67

QoQ Revenue Growth

-99.7%

Cash Flow

Operating Cash Flow

-$50M

Free Cash Flow

-$51M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$943M

Total Liabilities

$131M

Stockholders' Equity

$812M

Cash & Equivalents

$463M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$188,000	$237,000	-20.7%
Gross Profit	$188,000	-$40M	+100.5%
Operating Income	-$88M	-$48M	-83.8%
Net Income	-$85M	-$48M	-75.1%